This webinar program will focus on the theme of innovation and scientific engagement in Medical Communications, providing a detailed example of how a hackathon event is a valuable approach to enhance idea generation for a defined challenge and presents the opportunity to develop innovative “out-of-the box” solutions as a primary outcome of the event.
Introduction to external Education eLearning Course
Free to Members and Non-Members
If you are new to Medical Affairs, just getting started in developing your skills in medical education, or want a quick refresher, sign up for this e-learning module which provides an introduction and overview of all the different types of industry approaches to External Education (EE). The course will help you:
Learning activities/assessments: eLearning self-paced module with knowledge checks and a brief posttest
Approximate time to complete the activity: 30 minutes
Prerequisites: None
Audience: Beginner to Intermediate; For any Independent Medical Education (IME) and/or Medical Affairs professionals involved in External Education
Learning Objectives:
At the conclusion of this online learning activity, participants should be able to:
Activity Developers:
MAPS is appreciative of the following MAPS members and other individuals who were instrumental in creating the course content.
Independent Medical Education eLearning Course
FAWG Group: External Education
Member: Free
Non-Member: 135$
Interested in broadening your understanding of the different types of External Education in the spirit of omnichannel engagement, and more specifically in Independent Medical Education? Designed Specifically for Medical Affairs professionals working in the Independent Medical Education (IME) function, as well as, other MA Professionals involved in External Education (EE), This course:
The one-hour course will assist organizations to not only understand the breadth and depth of IME but also plan for upskilling their team as needed and enhance collaboration with other Medical Affairs and cross-functional partners to leverage synergies.
Learning activities/assessments: eLearning self-paced module, knowledge checks, and brief posttest (moderate difficulty)
Approximate time to complete the activity: 60 minutes
Prerequisites: The eLearning module “Introduction to External Education” is highly recommended.
Audience: Beginner to Intermediate; For any Independent Medical Education (IME) and/or Medical Affairs professionals involved in External Education
At the conclusion of this online learning activity, participants should be able to:
ACTIVITY DEVELOPERS:
MAPS is appreciative of the following MAPS members and other individuals who were instrumental in creating the course content.
In this webinar, we will show the views from a Therapeutic Area Lead responsible for establishing the insight objectives and ensuring action; a Field Medical Lead responsible for collecting and processing insights data; and a Strategic Program & Innovation Lead responsible for building & managing the program as well as ensuring actionable insight communication.
The objectives of this webinar are to present alternate views on a particular issue that is of concern to the Medical Affairs community while also attempting to resolve the issue.
In today’s episode, we’re talking with Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 about Artificial Intelligence — specifically about how AI can accelerate diagnosis and treatment.
In this episode, we’re talking about publications impact with Mike Taylor, Head of Data Insights and Grainne Farrell, Manager Corporate Life Science, Central Europe, both at Digital Science.
The COVID-19 pandemic led to the biggest change in scientific congresses in a generation, with virtual meetings becoming the mainstay. In that time, we have seen many big congresses offer different options, such as virtual exhibition booths, blogs, and podcasts. As we start to go back to live or hybrid options, we will discuss what we have learnt from the last 2 years to take forward to future congress offerings. We will also explore what HCPs want when joining congresses both virtually or face-to-face.
As speed of data sharing has become front of mind, congresses have also adapted to give alternative options to share certain types of key data, avoiding the need to wait months until the next annual congress. However, questions remain regarding reach and engagement with these new options.
Finally, what do we think the congress of the future will look like. How will congresses tackle DE&I and sustainability? Will we be using avatars and joining in the metaverse or will there always be a demand for face-to-face conversations. We will share our thoughts on innovative options we think will be adopted.
It is hard to overstate the expansion of Real-World Evidence (RWE) over the last 5 years. ISPOR has designated RWE the #1 trend in Health Economics for 2022-2023. Most new drug and biologics applications to FDA now include RWE information.
The use of RWE to support product label expansion has been a primary driver of interest in RWE. The 21st Century America Cures Act, enacted in 2016, required FDA to evaluate RWE in support of new drug indications. Since the Cures Act, FDA has issued multiple guidances and draft guidance statements regarding use of RWE for regulatory applications. The Agency has also utilized RWE in approving expanded indications for drug products. As FDA states at the top of its RWE web page, “Real-world data (RWD) and real-world evidence (RWE) are playing an increasing role in health care decisions.”
This virtual presentation will focus on 3 aspects of RWE:
1) What are RWE and Real-World Data (RWD), and how are they different?
2) What are relevant legal and regulatory considerations associated with using RWE for product label expansion?
3) How have applicants successfully used RWE to obtain approval for new drug and medical device indications?
In every successful organization there are fundamental business processes that create value and deliver a desired output. In life science companies, one of these processes is called commercialization. Commercialization of a health care product begins from the moment of concept creation. At that point, the innovator is thinking about how to treat a disease, make a patient’s life better, or meet an unmet medical need. Over time, value is built into the asset as it moves through the product development/commercialization pathway. Medical Affairs has a key role in this product development/commercialization pathway. Often referred to as a bridge between product development and commercial, Medical Affairs contributions are essential to deliver a successful commercialization process. Understanding the commercialization process and the role Medical Affairs plays in the overall organization will assist Medical Affairs professionals to make better decisions and optimize their ability to influence the future direction of their company.
This webinar seeks to help Medical Affairs professionals better understand the business of life science companies, how their efforts impact the overall capability to commercialize a product, and contemporary ways to bridge the commercialization interface between their department and Marketing & Sales. Topics included are a discussion on organizational operations and throughput, the importance of understanding the organization/enterprise main functions and how Medical Affairs aligns with functions, and optimizing interface between commercial and Medical Affairs. Our discussants will take a Medical Affairs-centric approach to discussing business operations management issues which should be useful for all Medical Affairs functions but particularly operations, therapeutic area leadership, and aspiring Medical Affairs managers.
Upon completion of the webinar, participants should be able to:
In this episode, experts discuss patient-centricity strategies and actions that make patient-first thinking the heart of your organization’s plans.